Results 241 to 250 of about 3,862 (291)

[Sympathomimetics in ADHD. Cardiovascular risks, FDA warns]

open access: yes, 2007
Östman-Smith, Ingegerd,   +1 more
core  

Sympathomimetics

Emergency Medicine Clinics of North America, 1990
Sympathomimetics have a long history of abuse. Initially amphetamines were abused for their adrenergic "rush"; now more sophisticated chemists have developed compounds that add a hallucinogenic component. Since the advent of crack and now "ice," the physician needs to recognize and treat appropriately those patients who present with the signs and ...
openaire   +2 more sources

Sympathomimetic enantiomers and asthma

Chirality, 1998
Airways of asthma patients can become hyperresponsive to airway spasmogens following regular use of isoprenaline or beta 2-selective sympathomimetics. Hyper-reactivity that results from acute exposure of animals to these drugs is pre-empted by vagal section (a procedure which does not influence spasmolytic efficacy of sympathomimetics), is not ...
D A, Handley   +3 more
openaire   +2 more sources

Quaternized Sympathomimetic Amines

Nature, 1963
IN their paper on sympathomimetic amines, Barger and Dale1 described the action of hordenine (the N : N-dimethyl derivative of tyramine), and showed that the quaternary derivative, hordenine methiodide (1; R′ = R″ = H), had a nicotine-like action.
J H, BURN, M F, CUTHBERT, R, WIEN
openaire   +2 more sources

Sympathomimetics in Nasal Allergy

ORL, 2010
The effect of a topically administered α-adrenoceptor agonist (phenylpropanolamine) after allergen challenge was evaluated in a placebo-controlled double-blind crossover study in 10 subjects with allergic rhinitis in an asymptomatic period. The nasal airway resistance was objectively measured by anterior rhinomanometry after nasal allergen challenge ...
M, Bende, L, Laurin
openaire   +2 more sources

Sympathomimetics, Inotropics, and Vasodilators

AACN Advanced Critical Care, 1992
Management of the critically ill patient often necessitates the use of multiple inotropic and vasoactive medications. This article offers a concise, clinical reference to guide the practicing clinician in the use of these agents. The focus is on parenteral agents used for acute rather than chronic management. Physiologic concepts basic to understanding
openaire   +2 more sources

Sympathomimetic Drugs in the Neonate

New England Journal of Medicine, 1980
S B, Yeager, J, Horbar, J F, Lucey
openaire   +2 more sources

Sympathomimetic bronchodilator drugs

Pharmacology & Therapeutics. Part B: General and Systematic Pharmacology, 1976
R T, Brittain, C M, Dean, D, Jack
openaire   +2 more sources

Home - About - Disclaimer - Privacy